SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm is trending due to its entrance into the AI chip market, highlighted by the launch of new AI200 and AI250 chips aimed at data centers, positioning it as a competitor to Nvidia and AMD. Community discussions revolve around the potential impact of these chips, particularly their power efficiency and customer base, with some analysts expressing skepticism about revenue projections. The move signifies Qualcomm's diversification beyond mobile chips into the growing AI infrastructure sector.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

United States Antimony Corp is trending amid discussions of a potential deal with Larvotto Resources, though some express concerns about valuation and potential dilution; the community is also weighing in on the broader implications of U.S.-China trade relations and domestic antimony supply chains, with many emphasizing UAMY's position as a key domestic refiner and producer of a critical mineral.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon is trending amid discussions about a potential activist investor campaign and NFL partnership, with the community debating whether these catalysts can reverse the stock's recent downturn. Some traders point to technical indicators suggesting a bottom, while others express concerns about market manipulation and the company's long-term prospects. Overall sentiment is mixed as investors weigh the potential impact of these developments on Lululemon's future performance.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is trending due to a temporary pause in gene therapy trials after a patient experienced a serious liver injury, leading to a significant drop in stock price. The community is debating whether this is an overreaction and a buying opportunity, with some focusing on the fact that it was a single patient out of many and the potential for trial resumption. Others are concerned about the implications for the gene editing sector and the company's cash burn.

This is a legacy token commemorating the pseudonym Satoshi Nakamoto.

Satoshi Nakamoto

$SATOSHI is trending as community members rally around the tokenization of Satoshi Nakamoto, viewing it as a cultural phenomenon and the 'BTC of memes'. Discussions highlight the project's potential for significant repricing and its representation of crypto's core values, with many emphasizing 'We are all Satoshi'.

Trump For President

The Trump Crypto token is experiencing volatility as the community debates its future and potential influence from political events. Community members are expressing concerns over potential market manipulation and overall project direction with some labeling it a scam. Despite the debate, there is speculation about a potential surge, while others remain bearish, pointing to the token's significant decline from its all-time high.

Energy Fuels, Inc. is a mining development company, which engages in the exploration and evaluation of uranium and vanadium properties. It also operates the Nichols Ranch, Alta Mesa, and White Mesa Mill projects. The company was founded by George E. L. Glasier and John David Mason on June 24, 1987 and is headquartered in Lakewood, CO.

Energy Fuels Inc

Energy Fuels ($UUUU) is trending due to significant call option activity, signaling potential insider knowledge of upcoming positive news or government contracts related to rare earth elements. The community is actively discussing large call sweeps and the potential for a short squeeze. The stock is further supported by a recent joint venture in Australia and a broader focus on domestic uranium production amid geopolitical tensions.

Lumen Technologies, Inc. is an investment holding company, which engages in the provision of integrated communications to residential and business customers. It operates through the Business and Mass Markets segments. The Business segment provides products and services under four sales channels to enterprise and commercial customers. The Mass Markets segment focuses on consumer and small business customers. The company was founded in 1930 and is headquartered in Monroe, LA.

Lumen Technologies Inc

Lumen Technologies is trending as investors anticipate Q3 earnings, focusing on the company's AI-driven growth strategy amid legacy business challenges. The community is discussing the potential impact of AI, a recent Palantir partnership, and government contracts on the stock's future. Some are speculating on price targets and a possible tech company rerating.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi is trending as investors anticipate positive earnings, with discussions around potential revenue beats, and are hopeful for a sustained climb. The community is also closely watching for news regarding interest rate decisions and potential S&P 500 inclusion, seeing these as possible catalysts for further gains. Bullish sentiment is high, with many expressing confidence in the company's long-term potential.

MaxsMaking, Inc. is a holding company, which engages in the manufacture of customized consumer goods. It offers a range of customizable textile products, including backpacks, thermal bags, canvas bags, aprons, throw pillows, flags, and advertising chair covers. The company was founded by Xiao Zhong Lin and Xue Fen Zhang in January 2007 and is headquartered in Shanghai, China.

MaxsMaking Inc. - Ordinary Shares - Class A

MaxsMaking Inc. Class A Ordinary Shares

MAMK is trending due to discussions around its low float and potential for manipulation, typical for textile companies. Community members are debating its volatile price action, with some anticipating a short squeeze while others express caution due to previous experiences with Chinese stocks. The stock's recent IPO status and high trading volume are also contributing to the heightened interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CERE Investors Have Opportunity to Join Cerevel Therapeutics Holdings, Inc. Fraud Investigation with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cerevel Therapeutics Holdings, Inc. (Cerevel or the Company...

As Traumatic Brain Injuries Increase, Global Concussion Market Size Expected to Reach $10 Billion By 2032

As Traumatic Brain Injuries Increase, Global Concussion Market Size Expected to Reach $10 Billion By 2032 As Traumatic Brain Injuries Increase, Global Concussion Market Size Expected to Reach $10...

CERE Investors Have the Opportunity to Join Investigation of Cerevel Therapeutics Holdings, Inc. with the Schall Law Firm

CERE Investors Have the Opportunity to Join Investigation of Cerevel Therapeutics Holdings, Inc. with the Schall Law Firm CERE Investors Have the Opportunity to Join Investigation of Cerevel...

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Cerevel Therapeutics Holdings, Inc. (Cerevel or the Company...

CEREVEL SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation into Fairness of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) Buyout and Encourages Investors to Contact the Firm

Kaskela Law LLC announces that it is investigating Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) (Cerevel) on behalf of the companys shareholders. On December 6, 2023, Cerevel announced that it...

Calling All Cerevel Therapeutics Holdings, Inc. (CERE) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Cerevel Therapeutics Holdings, Inc. ('Cerevel') (NASDAQ: CERE) and AbbVie, Inc. (AbbVie) (NYSE: ABBV...

CEREVEL INVESTOR NOTICE: Kaskela Law LLC Announces Investigation of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) and Encourages Investors to Contact the Firm

CEREVEL INVESTOR NOTICE: Kaskela Law LLC Announces Investigation of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) and Encourages Investors to Contact the Firm CEREVEL INVESTOR NOTICE: Kaskela...

Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Cerevel Therapeutics Holdings, Inc. ('Cerevel') (NASDAQ: CERE) and AbbVie, Inc. (AbbVie) (NYSE: ABBV...

NOTICE OF INVESTIGATION: Kaskela Law LLC Announces Shareholder Investigation of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) and Encourages Investors to Contact the Firm

NOTICE OF INVESTIGATION: Kaskela Law LLC Announces Shareholder Investigation of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) and Encourages Investors to Contact the Firm NOTICE OF...

Director N Coles Sells 50,000 Shares of Cerevel Therapeutics Holdings Inc (CERE)

Cerevel Therapeutics Holdings, Inc. engages in the discovery and development of new therapies for neuroscience diseases. The firm's portfolio focuses on diseases such as schizophrenia, epilepsy, and Parkinson's disease. Its product candidates include CVL-231, Darigabat, Tavapadon, CVL-871, and CVL-936. The company was founded in 2018 and is headquartered in Cambridge, MA.

Cerevel Therapeutics Holdings Inc

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

CERE
Cerevel Therapeutics Holdings Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CERE News

CERECerevel Therapeutics Holdings Inc